News

Innovative PoobahAI Welcomes Thousands of Builders Ahead of Launch

Innovative PoobahAI Welcomes Thousands of Builders Ahead of Launch

Innovative PoobahAI Welcomes Builders Ahead of Launch

Exciting news arises as PoobahAI, an innovative AI-driven no-code platform, gears up for its official release. Worldly, it has captured the attention of over 4,000 passionate developers and creators eager to join its waitlist. This burgeoning interest highlights a considerable demand for user-friendly, efficient, and cost-effective solutions in the realm of Web3 development.

Redefining No-Code Development for Web3

PoobahAI is set to transform the way individuals and enterprises approach blockchain technology. At its core, the platform aims to make Web3 development as accessible as conventional website creation. By utilizing its unique features, users can easily design and launch applications on various blockchains without requiring in-depth programming knowledge.

Empowering a New Generation of Builders

At the heart of PoobahAI's attraction is its no-code interface, which incorporates drag-and-drop functionality through components known as Digital Objects. These components encompass a diverse array of features, including tokens, NFT functionalities, and DeFi capabilities. This flexibility allows users to create comprehensive decentralized applications within weeks, rather than enduring cumbersome development cycles that extend for months.

Enhancing Accessibility in Web3

One of the most significant challenges in the tech landscape is the limited participation of developers in Web3, with a staggering fewer than 0.5% out of 28.7 million software engineers globally engaging in this space. Complexities such as high costs, steep technical requirements, and a fragmented collection of tools often hinder aspiring creators. PoobahAI seeks to dismantle these obstacles, enabling anyone with an idea to transform it into a functioning app effortlessly.

Valuable Insights from the Founder

“This milestone confirms what we’ve believed from the start: innovators everywhere are searching for tools that enhance accessibility in Web3,” expressed Dana Love, Ph.D., President and Chairman of PoobahAI. “The fact that over 4,000 individuals have expressed their intent to build with us before our launch speaks volumes about the market's pressing need for a platform like ours.”

Looking Ahead: Beta Program and Future Aspirations

For those who have secured their spots on the waitlist, exclusive early access is on the horizon as PoobahAI prepares to unveil its beta program later this year. This initiative gives pioneers the chance to experience the platform's capabilities firsthand and contribute valuable feedback as it continues to evolve.

About PoobahAI

Founded in July 2025, PoobahAI stands at the forefront of the no-code movement, merging artificial intelligence with blockchain technology. Founded by a team of experts that includes Dana Love, Brendan Cooper, Mant Hawkins, and Leif Sørensen, PoobahAI aspires to empower entrepreneurs and creators by drastically reducing development time and expenses. Its initial offerings include a multi-chain command-line interface and a user-friendly App Builder featuring over three dozen vetted Digital Objects. Showcase applications include secure cross-chain DeFi swaps, real asset tokenization, and an efficient NFT auction platform.

Frequently Asked Questions

What is PoobahAI?

PoobahAI is an AI-powered no-code platform designed to simplify Web3 application development, enabling users to create decentralized applications without coding skills.

How many people are currently on PoobahAI’s waitlist?

Over 4,000 developers and creators have joined PoobahAI’s waitlist, showcasing significant interest in the platform.

When will PoobahAI launch its beta program?

The beta program is set to roll out later this year, providing early adopters with priority access to the platform's features.

What features does PoobahAI offer?

PoobahAI provides a multi-chain command-line interface, a drag-and-drop app builder, and several showcase applications focusing on asset tokenization and DeFi solutions.

Who are the founders of PoobahAI?

PoobahAI was founded by Dana Love, Ph.D., Brendan Cooper, Mant Hawkins, and Leif Sørensen, who are experts in AI and Web3 technology.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

mF International Shuts Down Legacy Business to Focus on BCH

Updated Category News Views 0

mF International's Bold Digital Leap It’s a big move in the financial landscape when a firm decides to shake things up and pivot hard towards the digital frontier. mF International Limited (NASDAQ:MFI) is shutting the door on its legacy financial trading solutions and dedicating itself entirely to the budding world of digital assets. This isn’t just another facelift;...

Continue Reading
World Treadmill Championship: A New Run Begins

Updated Category News Views 7

A Run Like No Other I’ll bet you’ve heard it all when it comes to races—winding city marathons, grueling ultras with rough terrain, and everything in between. But a world championship on treadmills? Now that's a fresh spin! October 23rd, 2026 is when the RUN X™ World Treadmill Championship kicks off, stretching out across the planet in 400 fitness centres...

Continue Reading
MATIC S68 Wheels: A Bold Step for Superteam

Updated Category News Views 5

Premium Racing Takes a New Spin Scratch the surface of a tire-obsessed market, and you'll find Superteam Wheels making a calculated leap. Their new premium sub-brand, MATIC, isn't just fluff—it shows a serious attempt to impress those who’d rather cut corners on a track than a spreadsheet. Introducing the MATIC S68—buttery smooth, pitch-perfect, and undeniably...

Continue Reading
Podcast Giants Converge in Tennessee for POD U Summit

Updated Category News Views 0

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Continue Reading
Astra Security Tackles PHP2Shell Vulnerabilities Head-On

Updated Category News Views 2

Unlocking the PHP Puzzle Hot off the press, Astra Security's stepping up to the plate with some freebie tools designed to sniff out and stamp out those pesky PHP2Shell vulnerabilities—CVE-2026-109618 and CVE-2026-109619. If you're not familiar, these suckers rate a whopping 9.2 on the CVSS v4.0 scale, and that means they got the potential to let remote code execution...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 7

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 0

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Rising Food Safety Stars Honored: A Global Effort

Updated Category News Views 6

Food Safety Breakthrough: Youth Leads the Charge When it comes to food safety, it’s about time the younger crowd gets their due. The latest crew to step up to the plate is the Class of 2026's 40 Under 40 Food Safety Professionals. They’re not just pushing paper; these folks are setting the bar high and innovating across continents with real, tangible changes. From...

Continue Reading
Miraculous Medical Team Effort Saves Newborn's Life

Updated Category News Views 0

A Medical Feat: Teamwork at Its Pinnacle You want a story that restores your faith in humanity? Well, this one from Memorial Healthcare System and Joe DiMaggio Children's Hospital might just do the trick. The tale of baby Jay'ce, born with a neck mass threatening his breath, is straight out of a medical drama—albeit without the Hollywood scriptwriters' spin. It’s rare...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 0

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Partnership Boosts MoviePass's Growth with Sui

Updated Category News Views 58

Exploring the Sui and MoviePass Partnership The collaboration between Sui Foundation and MoviePass marks an exciting development in the way technology is transforming the moviegoing experience. Known for its innovations in blockchain, Sui Foundation has teamed up with MoviePass to improve its services, especially in the U.S. movie market. USDC Payment System Integration A...

Continue Reading
Leadership Changes at National Press Club Journalism Institute

Updated Category News Views 225

New Leadership at the National Press Club Journalism Institute In a significant move for journalism support, Ed Kelley has been appointed as the president of the National Press Club Journalism Institute for the term 2025-26. With a rich background in local media and academia, Kelley aims to continue the mission of empowering journalists to better serve their communities....

Continue Reading
Investors Warned of Potential Fraud at MoonLake Immunotherapeutics

Updated Category News Views 137

Concerns Over MoonLake Immunotherapeutics and Investor Trust Investors have raised alarms regarding MoonLake Immunotherapeutics (NASDAQ: MLTX) following allegations that the company misled its stakeholders about the potential of its drug, sonelokimab (SLK). The legal landscape is growing heated with a lawsuit alleging violations of securities laws against the company and...

Continue Reading
How AI Unlimited Group’s Lever App Transforms Student Loan Management

Updated Category News Views 187

Revolutionizing Student Loan Management with AI AI Unlimited Group Inc. (OTCQB: AIUG), based in Los Angeles, has launched a groundbreaking tool called the Lever App, designed specifically for student loan borrowers. This innovative app is making waves by addressing the persistent issues highlighted by the Consumer Financial Protection Bureau (CFPB) regarding student loan...

Continue Reading
Matinas BioPharma Welcomes New Board Member and Funding Deal

Updated Category News Views 108

Introduction to Recent Developments at Matinas BioPharma Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) is making headlines with its latest announcement about a major agreement involving the acquisition of preferred stock and the appointment of a new board member. This strategic move promises to bolster the company's position as a leading biopharmaceutical entity...

Continue Reading